Publisher
Springer Science and Business Media LLC
Reference102 articles.
1. Food and Drug Administration. Prevnar 13 label. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM201669.pdf . Accessed Jan 1, 2016.
2. Sanford M. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) in older adults. Drugs. 2012;72:1243–55.
3. Plosker GL. 13-Valent pneumococcal conjugate vaccine: a review of its use in adults. Drugs. 2015;75:1535–46.
4. Wise RP, Iskander J, Pratt RD, Campbell S, Ball R, Pless RP, Braun MM. Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA. 2004;292:1702–10.
5. Gruber WC, Scott DA, Emini EA. Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine. Ann NY Acad Sci. 2012;1263:15–26.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献